Gå til hovedindhold
Skip to main content
A highly specialised hospital in Denmark
A highly specialised hospital in Denmark
X
    Rigshospitalet
    A highly specialised hospital in Denmark
    A highly specialised hospital in Denmark
    • Departments
      Departments - Units - Sections - Centres
    • Research
      Professors - PhD projects - Research units - Research programmes
    • Careers
      Vacancies - Placements
    • About us
      Board of management - Strategy - Organisational diagram - Location map
    • Contact us
    • Patient information
    • News and media
    • Danish
    Rigshospitalet
    A highly specialised hospital in Denmark
    A highly specialised hospital in Denmark
    Skip Navigation LinksHome/Departments/Cancer and Organ Diseases, Centre for/Finsen Laboratory

    Finsen Laboratory

    ​The Finsen Laboratory is a basic cancer research department. We elucidate mechanisms of cancer initiation, maintenance and metastasis with the aim to identify biomarkers and novel targets for therapeutic intervention.​

     News from Finsen Laboratory

    10. January 2017

    Award winner on the hunt for leukaemia’s evil root

    Canadian Dr. John E. Dick is to receive Rigshospitalet’s International KFJ Award, and part of the honour is for his work in the fight against leukaemia.
    22. November 2016

    Big data enables new treatment of aggressive cancers

    Researchers from the Finsen Laboratory and BRIC in collaboration with researchers from Germany and Norway have developed a new computational method for analysis of large data material from thousands of cancer patients. These ‘big data’ can be used to understand how cancer genes are activated which enables targeted therapy especially for patients with aggressive tumours
    4. December 2015

    Researchers develop antibody to save cancerous bones

    ​A research group lead by Dr. Niels Behrendt and Dr. Lars Engelholm from the Finsen Laboratory and BRIC shows that Osteosarcoma cells degrade the bone tissue through a completely different process than metastasised bone cancer. Through treatment with a specific antibody, the researchers blocked the process and reduced up to 80% of bone degradation in a cancer mouse model.
    RSS
    Publishing date: 7/18/2022 3:46 PM

    Rigshospitalet

        Rigshospitalet

        Blegdamsvej 9

        2100 Copenhagen

        T (+45) 35 45 35 45

        E Skriv til os

        Rigshospitalet

        Valdemar Hansens Vej 1-23

        2600 Glostrup

        T (+45) 38 63 38 63​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​

        E Skriv til os

        • Copyright
        • Personal data policy
        • Cookies
        • Tilgængelighedserklæring
        Centre for Cancer and Organ Diseases